Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
April 02 2008 - 2:05PM
PR Newswire (US)
STEWARTVILLE, Minn., April 2, 2008 /PRNewswire-FirstCall/ --
Rochester Medical Corporation (NASDAQ:ROCM) applauds the improved
U.S. Medicare coverage policy that now allows intermittent catheter
users to benefit from not needing to reuse catheters. Effective
April 1, 2008, the four regional Durable Medical Equipment (DME)
Medicare Administrative Contractors (MAC) covering the United
States are implementing a new reimbursement policy covering the use
of Intermittent Catheters. The main policy change now allows an
intermittent catheter user a maximum of 200 catheters per month
instead of four catheters per month under previous policy.
Rochester Medical believes this is a very positive change in
helping reduce urinary tract infections and improving the quality
of life for Intermittent Catheter users. Rochester Medical
manufactures and markets a full line of advanced, all silicone
Intermittent Catheters including, the only Antibacterial and
Antibacterial Hydrophilic Intermittent Catheters in the
marketplace. The Company expects the updated Medicare coverage
policy will increase the usage of Intermittent Catheters and
increase Rochester Medical's sales of Intermittent Catheters in the
U.S. At this time it is difficult to project the full scale of the
change and the pace at which it will take effect. This press
release contains forward-looking statements that involve risks and
uncertainties, including the uncertainty of the impact of the
updated Medicare reimbursement policy for Intermittent Catheters
and other risk factors listed from time to time in the Company's
SEC reports and filings, including, without limitation, the section
entitled "Risk Factors" in the Company's Annual Report on Form 10-K
for the year ended September 30, 2007. Rochester Medical
Corporation develops, manufactures, and markets disposable medical
catheters and devices for urological and continence care
applications. The Company markets under its own Rochester
Medical(R) brand and under existing private label arrangements. For
further information, please contact Anthony J. Conway, President
and Chief Executive Officer of Rochester Medical Corporation at
(507) 533-9600. More information about Rochester Medical is
available on its website at http://www.rocm.com/. DATASOURCE:
Rochester Medical Corporation CONTACT: Anthony J. Conway, President
and Chief Executive Officer of Rochester Medical Corporation,
+1-507-533-9600 Web site: http://www.rocm.com/
Copyright
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2024 to Jun 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2023 to Jun 2024